Polynovo Ltd

PNV: XASX (AUS)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
LOCK|H@%m@f?LOCK|%>fLOCK|$y?g>sT

Polynovo Earnings: Strong Product Demand but Shares Appear Fairly Valued

Polynovo's fiscal 2025 sales rose 29%, led by a 29% increase in US sales to AUD 88 million. Growth was driven by its core synthetic skin product and growing adoption of its alternative product that has no sealing membrane, with the rest-of-world markets also contributing. Shares rose 9% on the day.

Sponsor Center